{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:22:29Z","timestamp":1784071349805,"version":"3.55.0"},"reference-count":18,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.247.69","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T17:33:51Z","timestamp":1548783231000},"page":"69-73","source":"Crossref","is-referenced-by-count":15,"title":["Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease"],"prefix":"10.1620","volume":"247","author":[{"given":"Haruka","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Kozu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yaoita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Tatebe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Capdeville, R., Buchdunger, E., Zimmermann, J. &amp; Matter, A. (2002)  Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.  <i>Nat. Rev. Drug Discov<\/i>., 1, 493-502.","DOI":"10.1038\/nrd839"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Dai, Z. &amp; Matsui, Y. (2014)  Pulmonary veno-occlusive disease: an 80-year-old mystery.  <i>Respiration<\/i>, 88, 148-157.","DOI":"10.1159\/000359973"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Gali\u00e8, N., Humbert, M., Vachiery, J.L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., Gomez Sanchez, M.A., Hansmann, G., Klepetko, W., Lancellotti, P.,  et al. (2016)  2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).  <i>Eur. Heart J<\/i>., 37, 67-119.","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Ghofrani, H.A., Seeger, W. &amp; Grimminger, F. (2005)  Imatinib for the treatment of pulmonary arterial hypertension.  <i>N. Engl. J. Med<\/i>., 353, 1412-1413.","DOI":"10.1056\/NEJMc051946"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Hoeper, M.M., Barst, R.J., Bourge, R.C., Feldman, J., Frost, A.E., Galie, N., Gomez-Sanchez, M.A., Grimminger, F., Grunig, E., Hassoun, P.M., Morrell, N.W., Peacock, A.J., Satoh, T., Simonneau, G., Tapson, V.F.,  et al. (2013)  Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.  <i>Circulation<\/i>, 127, 1128-1138.","DOI":"10.1161\/CIRCULATIONAHA.112.000765"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Holcomb, B.W. Jr., Loyd, J.E., Ely, E.W., Johnson, J. &amp; Robbins, I.M. (2000)  Pulmonary veno-occlusive disease: a case series and new observations.  <i>Chest<\/i>, 118, 1671-1679.","DOI":"10.1378\/chest.118.6.1671"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Koiwa, H., Tsujino, I., Ikeda, D., Ohira, H., Tanino, M. &amp; Nishimura, M. (2011)  An autopsy case of pulmonary veno-occlusive disease refractory to imatinib.  <i>Eur. Respir. J<\/i>., 37, 968-970.","DOI":"10.1183\/09031936.00095710"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Mandel, J., Mark, E.J. &amp; Hales, C.A. (2000)  Pulmonary veno-occlusive disease.  <i>Am. J. Respir. Crit. Care Med<\/i>., 162, 1964-1973.","DOI":"10.1164\/ajrccm.162.5.9912045"},{"key":"9","doi-asserted-by":"crossref","unstructured":"McGoon, M., Gutterman, D., Steen, V., Barst, R., McCrory, D.C., Fortin, T.A. &amp; Loyd, J.E.; American College of Chest Physicians  (2004)  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.  <i>Chest<\/i>, 126, 14S-34S.","DOI":"10.1378\/chest.126.1_suppl.14S"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Montani, D., Achouh, L., Dorfmuller, P., Le Pavec, J., Sztrymf, B., Tcherakian, C., Rabiller, A., Haque, R., Sitbon, O., Jais, X., Dartevelle, P., Maitre, S., Capron, F., Musset, D., Simonneau, G.,  et al. (2008)  Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.  <i>Medicine<\/i> (<i>Baltimore<\/i>), 87, 220-233.","DOI":"10.1097\/MD.0b013e31818193bb"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Montani, D., Jais, X., Price, L.C., Achouh, L., Degano, B., Mercier, O., Mussot, S., Fadel, E., Dartevelle, P., Sitbon, O., Simonneau, G. &amp; Humbert, M. (2009)  Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease.  <i>Eur. Respir. J.<\/i>, 34, 1348-1356.","DOI":"10.1183\/09031936.00017809"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Montani, D., Lau, E.M., Dorfmuller, P., Girerd, B., Jais, X., Savale, L., Perros, F., Nossent, E., Garcia, G., Parent, F., Fadel, E., Soubrier, F., Sitbon, O., Simonneau, G. &amp; Humbert, M. (2016)  Pulmonary veno-occlusive disease.  <i>Eur. Respir. J.<\/i>, 47, 1518-1534.","DOI":"10.1183\/13993003.00026-2016"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ogawa, A., Miyaji, K. &amp; Matsubara, H. (2017)  Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.  <i>Respir. Med.<\/i>, 131, 215-219.","DOI":"10.1016\/j.rmed.2017.08.032"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Overbeek, M.J., Boonstra, A., Voskuyl, A.E., Vonk, M.C., Vonk-Noordegraaf, A., van Berkel, M.P., Mooi, W.J., Dijkmans, B.A., Hondema, L.S., Smit, E.F. &amp; Grunberg, K. (2011)  Platelet-derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study.  <i>Arthritis Res. Ther.<\/i>, 13, R61.","DOI":"10.1186\/ar3315"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Overbeek, M.J., van Nieuw Amerongen, G.P., Boonstra, A., Smit, E.F. &amp; Vonk-Noordegraaf, A. (2008)  Possible role of imatinib in clinical pulmonary veno-occlusive disease.  <i>Eur. Respir. J.<\/i>, 32, 232-235.","DOI":"10.1183\/09031936.00054407"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Perros, F., Montani, D., Dorfmuller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., Herve, P., Emilie, D., Eddahibi, S., Simonneau, G., Souza, R.,  et al. (2008)  Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.  <i>Am. J. Respir. Crit. Care Med.<\/i>, 178, 81-88.","DOI":"10.1164\/rccm.200707-1037OC"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Schermuly, R.T., Dony, E., Ghofrani, H.A., Pullamsetti, S., Savai, R., Roth, M., Sydykov, A., Lai, Y.J., Weissmann, N., Seeger, W. &amp; Grimminger, F. (2005)  Reversal of experimental pulmonary hypertension by PDGF inhibition.  <i>J. Clin. Invest.<\/i>, 115, 2811-2821.","DOI":"10.1172\/JCI24838"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Wille, K.M., Sharma, N.S., Kulkarni, T., Lammi, M.R., Barney, J.B., Bellot, S.C., Cantor, R.S., Naftel, D.C., Diaz-Guzman, E. &amp; McGiffin, D.C. (2014)  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.  <i>Ann. Am. Thorac. Soc.<\/i>, 11, 1411-1418.","DOI":"10.1513\/AnnalsATS.201408-354OC"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/2\/247_69\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:34:47Z","timestamp":1549067687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/2\/247_69\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.247.69","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}